140
Participants
Start Date
December 31, 2016
Primary Completion Date
June 5, 2024
Study Completion Date
November 30, 2034
Controlled ovarian hyperstimulation (COH)
"After information and consent, patients are addressed to a reproductive medicine center.~The COH will be performed according to a standardized protocol between surgery and the start of adjuvant chemotherapy. Follicular growth will be achieved with an antagonist protocol and by using high dose recombinant FSH (r-FSH). The triggering of the final follicular and oocyte maturation will be obtained by a GnRH (Gonadotropin Releasing Hormone) agonist injection in order to minimize the risk of ovarian hyper-stimulation."
Oocyte/embryo freezing
Egg or embryo freezing will be performed according to a standardized protocol: slow-freezing process for embryo; vitrification technique for oocytes. Cryopreserved oocytes and embryos will be stored in the biological bank of each reproductive medicine center (min. 10 years).
CHU La Conception, Marseille
Institut Paoli Calmette, Marseille
CHU de Caen, Caen
Centre François Baclesse, Caen
Centre Georges François LECLERC, Dijon
CHU de Dijon, Dijon
Oncopole-CHU Toulouse, Toulouse
Centre Aliénor d'Aquitaine, Hôpital Pellegrin, Bordeaux
CHRU Montpellier, Montpellier
ICM - Val d'Aurelle, Montpellier
CHRU de Nancy, Nancy
Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy
Centre Oscar Lambret, Lille
CHRU Hôpital Jeanne de Flandres, Lille
Hôpital Universitaire de Strasbourg, Strasbourg
CHU Lyon, Lyon
Centre Léon Bérard, Lyon
Institut Curie, Paris
Hôpital Cochin, Paris
Hôpital TENON, Paris
CHU Rouen, Rouen
Centre Henri Becquerel, Rouen
CHU Limoges, Limoges
Hôpital Antoine Béclère, Clamart
Institut Curie, Saint-Cloud
Hôpital Jean Verdier, Bondy
Institut Gustave Roussy, Villejuif
CHU REUNION site SUD, La Réunion
University Hospital, Lille
OTHER
National Cancer Institute, France
OTHER_GOV
University Hospital, Montpellier
OTHER
Centre Oscar Lambret
OTHER